| RS2513336377 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2513337093 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513337260 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2513338680 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513339653 |
TDRD12
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS2513342452 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2513344634 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2513344818 |
KMT2B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 68 |
| RS2513344824 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2513344926 |
KMT2B
|
Health Risk |
Likely pathogenic |
KMT2B-related disorder, KMT2B-related disorder |
| RS2513344954 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2513345836 |
KMT2B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 68 |
| RS2513346049 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS2513346396 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2513348956 |
DNM2
|
Health Risk |
Likely pathogenic |
Autosomal dominant centronuclear myopathy, Charcot-Marie-Tooth disease dominant intermediate B |
| RS2513349459 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513350024 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513350390 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2513352916 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2513355378 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513356252 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513357403 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS2513365069 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513365471 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 28, childhood-onset |
| RS2513366517 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513366562 |
KMT2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2513370231 |
KMT2B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2513370236 |
KMT2B
|
Health Risk |
Pathogenic |
— |
| RS2513370317 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS2513375040 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513375048 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513380433 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513380450 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513380789 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS2513384226 |
TGFB1
|
Health Risk |
Likely pathogenic |
Inflammatory bowel disease, immunodeficiency |
| RS2513391100 |
CRLF1
|
Health Risk |
Likely pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome 1 |
| RS2513391263 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2513391862 |
ZNF699
|
Health Risk |
Likely pathogenic |
ZNF699-related disorder, ZNF699-related disorder |
| RS2513392622 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS2513393044 |
WDR62
|
Health Risk |
Likely pathogenic |
Autosomal recessive primary microcephaly, Microcephaly 2 |
| RS2513396318 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513396675 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513397063 |
ZNF699
|
Health Risk |
Pathogenic |
DEGCAGS syndrome, DEGCAGS syndrome |
| RS2513397377 |
CRLF1
|
Health Risk |
Likely pathogenic |
Cold-induced sweating syndrome, Cold-induced sweating syndrome |
| RS2513397402 |
CRLF1
|
Health Risk |
Likely pathogenic |
Cold-induced sweating syndrome, Cold-induced sweating syndrome |
| RS2513398193 |
B9D2
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2513408240 |
B9D2
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2513410026 |
PEPD
|
Health Risk |
Likely pathogenic |
PEPD-related disorder, PEPD-related disorder |
| RS2513410277 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS2513412559 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513442799 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS2513443720 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513443827 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513443854 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513443919 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS2513452038 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2513452044 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2513452055 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513452174 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513452327 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513452355 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513452367 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513452452 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454220 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS2513454323 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454343 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454359 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454376 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454434 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513454904 |
WDR62
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS2513457448 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS2513457503 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459631 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459641 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459717 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459729 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459825 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513459912 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513460449 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513460454 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513460533 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513460625 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513460977 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2513461024 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS2513461198 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS2513461217 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513462216 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513462321 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513462327 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513462341 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2513465496 |
PEPD
|
Health Risk |
Pathogenic |
— |
| RS2513477443 |
TCF3
|
Health Risk |
Pathogenic |
— |
| RS2513481945 |
TDRD12
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS2513492203 |
TCF3
|
Health Risk |
Pathogenic |
— |
| RS2513492691 |
TCF3
|
Health Risk |
Pathogenic |
— |
| RS2513493190 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS2513496574 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS2513503626 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2513503660 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2513503702 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |